207940:KRX
Samsung Biologics Co Ltd
â‚©1,298,000.00
arrow_upward
+0.15%(+2,000.00) 1D
Jun 10, 3:30:01 PM GMT+9 · KRW
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 207940...
Open
â‚©1,291,000
High
â‚©1,305,000
Low
â‚©1,253,000
Mkt. cap
60.09T
Avg. vol.
66.30K
Volume
44.56K
P/E ratio
29.54
52-wk high
â‚©1,987,000
52-wk low
â‚©982,000
EPS
â‚©43,947
Shares outstanding
46.29M
No. of employees
5K
Open
â‚©1,291,000
High
â‚©1,305,000
Low
â‚©1,253,000
Mkt. cap
60.09T
Avg. vol.
66.30K
Volume
44.56K
P/E ratio
29.54
52-wk high
â‚©1,987,000
52-wk low
â‚©982,000
EPS
â‚©43,947
Shares outstanding
46.29M
No. of employees
5K
News stories
From sources across the web
AD HOC NEWS
·
1 day ago
Infineon’s 5.25% Rebound Caps a 26.87% Monthly Surge as DAX Momentum Leaders Face a Reality Check
AD HOC NEWS
·
19 hours ago
Deutsche Börse AG stock (DE0005810055): guidance raised after strong Q1 and index business boost
www.marketscreener.com
·
21 hours ago
DAX Index Declines; German Industrial Output Climbs
AD HOC NEWS
·
2 days ago
BASF SE stock (DE000BASF111): Analyst focus as DAX heavyweight trades around EUR 51
Profile
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
About Samsung Biologics Co Ltd
AI content may include mistakes. Learn more